IPSC - Wall Street Estimates - Century Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 0.6381

-6.55 %

$ 54.3 M

Market Cap

-0.35

P/E

Price Target Average

1825.36%

Revenue Forecast Estimate

309.17%

EBIT Estimate

30.24%

Net Income Estimate

8.47%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Century Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for IPSC of $12.3 , with forecasts ranging from a low of $5 to a high of $25 .

IPSC Lowest Price Target Wall Street Target

5 USD 683.58%

IPSC Average Price Target Wall Street Target

12.3 USD 1825.36%

IPSC Highest Price Target Wall Street Target

25 USD 3817.88%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free